ESC 365 - Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II

ESC Professional Premium Access

Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Topic: Pharmacotherapy

Speaker: Doctor T. Gu (Tianjin, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tianshu Gu

2nd Hospital of Tianjin Medical University, Tianjin (China)

0 follower

6 more presentations in this session

Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial

Speaker: Ms M. Lin (Hong Kong, HK)

Exploring the long-term effects of dapagliflozin in patients with stable acute myocardial infarction and preserved ejection fraction through a propensity score matching study

Speaker: Doctor B. Hsiao (Taipei, TW)

Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials

Speaker: Professor J. Carson (New Brunswick, US)

CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats

Speaker: Professor Y. Wang (Kunming, CN)

Drug-coated balloon for de-novo coronary artery lesions exceeding 2.5 mm in diameter: optical coherence tomography analysis and clinical follow-up

Speaker: Doctor L. Guo (Dalian, CN)

Access the full session

Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Speakers: Doctor T. Gu, Ms M. Lin, Doctor B. Hsiao, Professor J. Carson, Professor Y. Wang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources